导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 9.31% | 311/1050 |
| 近一周 | -2.65% | 677/1104 |
| 近一月 | -2.90% | 388/1102 |
| 近一季 | -3.46% | 506/1092 |
| 近半年 | -1.09% | 462/1070 |
| 近一年 | 15.29% | 294/1018 |
| 近两年 | 131.33% | 120/926 |
| 近三年 | 73.78% | 134/833 |
| 成立以来 | 63.58% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.78% 210/1070 |
15.23% 445/1101 |
- - |
- - |
| 2025 | 50.95% 185/1065 |
10.11% 147/1014 |
14.26% 44/1038 |
15.76% 731/1050 |
3.65% 211/1065 |
| 2024 | 2.84% 504/1011 |
-10.82% 791/960 |
-8.50% 807/983 |
17.35% 121/991 |
7.41% 87/1011 |
| 2023 | 4.38% 47/952 |
10.08% 117/880 |
0.27% 172/895 |
-6.70% 404/915 |
1.35% 83/952 |
| 2022 | - - |
- - |
- - |
- - |
0.79% 401/867 |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 银华专精特新量化优选股票发起A VS. 东吴新产业精选股票A(580008) |